A novel target of EZH1/2 for treatment of mantle cell lymphoma

Yuki Kagiyama

Presentation information

Oral Session

Oral Session 1-7D Maliginant lymphoma: Basic (4)

Fri. Oct 12, 2018 4:20 PM - 5:20 PM No.7 (Osaka International Convention Center, 10F 1001)

Chair: Akihiro Tomita (Department of Hematology, Fukuoka Health University School of Medicine, Japan)

[OS1-7D-1] A novel target of EZH1/2 for treatment of mantle cell lymphoma

Yuki Kagiyama¹, Shuhei Fujita¹, Makoto Nakagawa¹, Daisuke Honma², Nobuaki Adachi², Kazushi Araki², Ayako Kato³, Koichiro Inaki³, Yoshimasa Ono³, Suguru Fukuhara⁴, Yukio Kobayashi⁴, Kensei Tobinai⁴, Issay Kitabayashi¹ (1.Hematological Malignancy, Natl. Cancer Ctr. Res. Inst., Tokyo, Japan, 2.Oncol. Lab., Daiichi Sankyo, Tokyo, Japan, 3.Disc. Sci. & Tech. Dept., Daiichi Sankyo RD Novare, Tokyo, Japan, 4.Dept. of Hematol., Natl. Cancer Ctr. Hosp, Tokyo, Japan)

Abstract password authentication.
Password is written on a program and abstract book.